DE60105411D1 - Verfahren zur diagnose von krebs - Google Patents
Verfahren zur diagnose von krebsInfo
- Publication number
- DE60105411D1 DE60105411D1 DE60105411T DE60105411T DE60105411D1 DE 60105411 D1 DE60105411 D1 DE 60105411D1 DE 60105411 T DE60105411 T DE 60105411T DE 60105411 T DE60105411 T DE 60105411T DE 60105411 D1 DE60105411 D1 DE 60105411D1
- Authority
- DE
- Germany
- Prior art keywords
- diagnosing cancer
- diagnosing
- cancers
- rna
- evolution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00111370A EP1158055A1 (de) | 2000-05-26 | 2000-05-26 | Verfahren zur Diagnose von Krebs |
EP00111370 | 2000-05-26 | ||
PCT/IB2001/000852 WO2001090409A1 (fr) | 2000-05-26 | 2001-05-16 | Methode pour le diagnostic de cancers |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60105411D1 true DE60105411D1 (de) | 2004-10-14 |
DE60105411T2 DE60105411T2 (de) | 2005-09-22 |
Family
ID=8168848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60105411T Expired - Lifetime DE60105411T2 (de) | 2000-05-26 | 2001-05-16 | Verfahren zur diagnose von krebs |
Country Status (8)
Country | Link |
---|---|
US (1) | US7163789B2 (de) |
EP (2) | EP1158055A1 (de) |
AT (1) | ATE275642T1 (de) |
AU (1) | AU5502101A (de) |
DE (1) | DE60105411T2 (de) |
ES (1) | ES2227178T3 (de) |
PT (1) | PT1283907E (de) |
WO (1) | WO2001090409A1 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6607898B1 (en) | 1996-03-26 | 2003-08-19 | Oncomedx, Inc. | Method for detection of hTR and hTERT telomerase-associated RNA in plasma or serum |
US20030158673A1 (en) * | 2002-02-16 | 2003-08-21 | Ingene Institut Fur Genetische Medizin Gmbh | Method for creating a blood bank with associated data bank |
ITMI20022743A1 (it) | 2002-12-23 | 2004-06-24 | Ist Naz Stud Cura Dei Tumori | Metodo per la determinazione del rischio di comparsa, della presenza o del decorso di malattie tumorali. |
EP1528107B1 (de) * | 2003-10-29 | 2006-11-22 | Maurice Stroun | Verfahren zur Diagnose von Krebs |
ATE406463T1 (de) | 2005-04-06 | 2008-09-15 | Maurice Stroun | Methode zur krebsdiagnose mittels nachweis von dna und rna im kreislauf |
IL301804A (en) | 2006-05-18 | 2023-05-01 | Caris Mpi Inc | A system and method for determining a personalized medical intervention for a disease stage |
US8768629B2 (en) * | 2009-02-11 | 2014-07-01 | Caris Mpi, Inc. | Molecular profiling of tumors |
US8614057B2 (en) * | 2008-06-12 | 2013-12-24 | The Invention Science Fund I, Llc | Methods for collecting and detecting oligonucleotides |
US8252529B2 (en) * | 2008-06-12 | 2012-08-28 | The Invention Science Fund I, Llc | Methods for collecting and detecting oligonucleotides |
US8252528B2 (en) * | 2008-06-12 | 2012-08-28 | The Invention Science Fund I, Llc | Methods, compositions, and kits for collecting and detecting oligonucleotides |
JP2012508577A (ja) * | 2008-11-12 | 2012-04-12 | カリス ライフ サイエンシズ ルクセンブルク ホールディングス | 表現型を決定するためのエキソソームの使用方法およびそのシステム |
CN103237901B (zh) | 2010-03-01 | 2016-08-03 | 卡里斯生命科学瑞士控股有限责任公司 | 用于治疗诊断的生物标志物 |
KR20130043104A (ko) | 2010-04-06 | 2013-04-29 | 카리스 라이프 사이언스 룩셈부르크 홀딩스 | 질병용 순환 생물학적 지표들 |
EP4269623A3 (de) | 2010-11-30 | 2024-03-06 | The Chinese University Of Hong Kong | Analyse einer biologischen probe eines organismus auf mit krebs assoziierte chromosomale deletionen oder amplifikationen |
WO2013052168A2 (en) * | 2011-05-26 | 2013-04-11 | Georgetown University | Detection aib1-delta 4 protein |
US10876152B2 (en) | 2012-09-04 | 2020-12-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US11913065B2 (en) | 2012-09-04 | 2024-02-27 | Guardent Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US20160040229A1 (en) | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
KR102393608B1 (ko) | 2012-09-04 | 2022-05-03 | 가던트 헬쓰, 인크. | 희귀 돌연변이 및 카피수 변이를 검출하기 위한 시스템 및 방법 |
ES2784450T3 (es) | 2013-12-28 | 2020-09-25 | Guardant Health Inc | Métodos y sistemas para detectar variantes genéticas |
US11302416B2 (en) | 2015-09-02 | 2022-04-12 | Guardant Health | Machine learning for somatic single nucleotide variant detection in cell-free tumor nucleic acid sequencing applications |
JP2019507585A (ja) | 2015-12-17 | 2019-03-22 | ガーダント ヘルス, インコーポレイテッド | 無細胞dnaの分析による腫瘍遺伝子コピー数を決定するための方法 |
SG11201811159SA (en) | 2016-09-30 | 2019-01-30 | Guardant Health Inc | Methods for multi-resolution analysis of cell-free nucleic acids |
US9850523B1 (en) | 2016-09-30 | 2017-12-26 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
US10907211B1 (en) | 2017-02-16 | 2021-02-02 | Quantgene Inc. | Methods and compositions for detecting cancer biomarkers in bodily fluids |
US11643693B2 (en) | 2019-01-31 | 2023-05-09 | Guardant Health, Inc. | Compositions and methods for isolating cell-free DNA |
US11475981B2 (en) | 2020-02-18 | 2022-10-18 | Tempus Labs, Inc. | Methods and systems for dynamic variant thresholding in a liquid biopsy assay |
US11211144B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Methods and systems for refining copy number variation in a liquid biopsy assay |
US11211147B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4699877A (en) | 1982-11-04 | 1987-10-13 | The Regents Of The University Of California | Methods and compositions for detecting human tumors |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US5274087A (en) | 1986-08-13 | 1993-12-28 | Molecular Diagnostics, Inc. | cDNA coding for carcinoembryonic antigen (CEA) |
DE3717212A1 (de) | 1987-05-22 | 1988-12-08 | Viktor Dr Dr Med Balazs | Verfahren zur untersuchung einer azellularen biologischen fluessigkeit auf zellulare onkogen-transkripte bzw. deren fragmente |
US5124246A (en) | 1987-10-15 | 1992-06-23 | Chiron Corporation | Nucleic acid multimers and amplified nucleic acid hybridization assays using same |
CA1340807C (en) | 1988-02-24 | 1999-11-02 | Lawrence T. Malek | Nucleic acid amplification process |
US4874858A (en) | 1988-03-28 | 1989-10-17 | The B. F. Goodrich Company | Triazine-containing multisilane coupling agents for coating glass fibers, for adhesives, and for protective coatings |
US4999290A (en) | 1988-03-31 | 1991-03-12 | The Board Of Regents, The University Of Texas System | Detection of genomic abnormalities with unique aberrant gene transcripts |
US5098890A (en) | 1988-11-07 | 1992-03-24 | Temple University-Of The Commonwealth System Of Higher Education | Antisence oligonucleotides to c-myb proto-oncogene and uses thereof |
US5087617A (en) | 1989-02-15 | 1992-02-11 | Board Of Regents, The University Of Texas System | Methods and compositions for treatment of cancer using oligonucleotides |
EP0458831A1 (de) | 1989-02-16 | 1991-12-04 | BALAZS, Viktor, Dr. Dr. med. | Malignitätstest (krebs-test) mit verwendung von der polymerasekettenreaktion |
US5217889A (en) | 1990-10-19 | 1993-06-08 | Roninson Igor B | Methods and applications for efficient genetic suppressor elements |
US5155018A (en) | 1991-07-10 | 1992-10-13 | Hahnemann University | Process and kit for isolating and purifying RNA from biological sources |
WO1993017127A1 (en) | 1992-02-20 | 1993-09-02 | The State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University | Boomerand dna amplification |
US5300635A (en) | 1993-02-01 | 1994-04-05 | University Of Iowa Research Foundation | Quaternary amine surfactants and methods of using same in isolation of nucleic acids |
DE59609347D1 (de) * | 1995-11-16 | 2002-07-18 | Michael W Dahm | Verfahren zur quantifizierung von tumorzellen in einer körperflüssigkeit und dazu geeignete testkits |
US5817461A (en) * | 1996-01-03 | 1998-10-06 | Hamilton Civic Hospitals Research Development Inc. | Methods and compositions for diagnosis of hyperhomocysteinemia |
WO1997035589A1 (en) | 1996-03-26 | 1997-10-02 | Kopreski Michael S | Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
US6607898B1 (en) * | 1996-03-26 | 2003-08-19 | Oncomedx, Inc. | Method for detection of hTR and hTERT telomerase-associated RNA in plasma or serum |
US6610839B1 (en) * | 1997-08-14 | 2003-08-26 | Geron Corporation | Promoter for telomerase reverse transcriptase |
CA2266752A1 (en) * | 1996-10-01 | 1998-04-09 | Geron Corporation | Telomerase reverse transcriptase |
WO1998028442A1 (en) * | 1996-12-20 | 1998-07-02 | Geron Corporation | Methods for detecting and inhibiting the rna component of telomerase |
DE19757300A1 (de) * | 1997-12-22 | 1999-06-24 | Roche Diagnostics Gmbh | Nachweis von Harnblasenkarzinom in einer Urinprobe |
DE19804372A1 (de) | 1998-02-04 | 1999-08-05 | Michael W Dr Dr Dahm | Verfahren zur quantitativen Bestimmung von Tumorzellen in einer Körperflüssigkeit und dazu geeignete Testkits |
CA2321259A1 (en) * | 1998-02-16 | 1999-08-19 | University Of Maryland, Baltimore | Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis |
US6639057B1 (en) * | 1998-03-26 | 2003-10-28 | Kyowa Hakko Kogyo Co., Ltd. | Monoclonal antibody against human telomerase catalytic subunit |
-
2000
- 2000-05-26 EP EP00111370A patent/EP1158055A1/de not_active Withdrawn
-
2001
- 2001-05-16 US US10/296,739 patent/US7163789B2/en not_active Expired - Lifetime
- 2001-05-16 DE DE60105411T patent/DE60105411T2/de not_active Expired - Lifetime
- 2001-05-16 PT PT01928158T patent/PT1283907E/pt unknown
- 2001-05-16 ES ES01928158T patent/ES2227178T3/es not_active Expired - Lifetime
- 2001-05-16 AT AT01928158T patent/ATE275642T1/de active
- 2001-05-16 EP EP01928158A patent/EP1283907B1/de not_active Expired - Lifetime
- 2001-05-16 AU AU55021/01A patent/AU5502101A/en not_active Abandoned
- 2001-05-16 WO PCT/IB2001/000852 patent/WO2001090409A1/fr active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
PT1283907E (pt) | 2005-01-31 |
US20040132019A1 (en) | 2004-07-08 |
US7163789B2 (en) | 2007-01-16 |
WO2001090409A1 (fr) | 2001-11-29 |
EP1283907A1 (de) | 2003-02-19 |
AU5502101A (en) | 2001-12-03 |
DE60105411T2 (de) | 2005-09-22 |
EP1158055A1 (de) | 2001-11-28 |
ATE275642T1 (de) | 2004-09-15 |
ES2227178T3 (es) | 2005-04-01 |
EP1283907B1 (de) | 2004-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60105411D1 (de) | Verfahren zur diagnose von krebs | |
MY133942A (en) | Reagent test strip for analyte determination having hemolyzing agent | |
DE60238493D1 (de) | Is von seltenen zellen verwendete markierte zellen | |
ATE394658T1 (de) | Spurendetektion von analyten mit hilfe artifizieller olfaktometrie | |
DE60137203D1 (de) | Poröse ferro- oder ferrimagnetische glasteilchen für molekültrennung | |
DE60042695D1 (de) | Verfahren für den nachweis von erkrankungen | |
DE69941044D1 (de) | Methoden, Apparat und Computerprogramm zur quantitativen Bestimmung von Nukleinsäurensequenzen in Proben unter Verwendung von Standardkurven und Abschätzungen von Amplifikationsverhältnissen | |
TWI256975B (en) | Compositions containing a urea derivative dye for detecting an analyte and methods for using the same | |
DE59903915D1 (de) | Verfahren zur frühen diagnose von carcinomen | |
DE60041355D1 (de) | Verfahren zur detektion von erkrankungen | |
DE69929882D1 (de) | Verfahren und vorrichtung zur nukleinsäurereinigung | |
ATE510927T1 (de) | Verfahren zur quantitativen bestimmung von tumorzellen in einer körperflüssigkeit und dazu geeignete testkits | |
ES2183399T3 (es) | Metodo para la determinacion del funcionamiento del higado. | |
ATE372392T1 (de) | Verfahren zur bestimmung der menge einer zielnukleinsäure in einer probe | |
WO2004109286A3 (en) | Methods for detecting and treating cancer using podocalyxin and/or endoglycan | |
ATE513058T1 (de) | Verdrängungsassay zur detektion von nukleinsäureoligomer-hybridisierungsereignissen | |
ATE380584T1 (de) | Hybridverfahren zur herstellung von trägern für die analytbestimmung | |
DE10292255D2 (de) | Verfahren für biochemische Nachweise von Analyten | |
DE69903380D1 (de) | Reagenz und Methode zur Permeabilisierung und zur Identifizierung von Erythrozyten | |
ATE429440T1 (de) | Formen prostataspezifischer antigene und verfahren zu deren nachweis | |
DE60012723D1 (de) | Verfahren zur bestimmung von disaccharidasen | |
ATE346170T1 (de) | Verfahren zur diagnose von krebs | |
DE60212930D1 (de) | Detektionsmethode für Zielmoleküle, Reagenz sowie Verfahren zur Detektion von SNPs in DNA Nukleotidsequenzen | |
EP1241269A3 (de) | Verfahren zum Nachweiss von REG-ähnliches Protein und dafür kodierende Nukleinäuren | |
WO2003001212A3 (en) | A method for diagnosing a person having multiple sclerosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent |